Health Podcast Library
The MM+M Podcast
Episode 352

Brukinsa approval raises BeiGene’s hematology profile

Mar 20, 2024
36:00
Promote

Episode Description

BeiGene’s chief medical officer for hematology, Dr. Mehrdad Mobasher, tells Jack O'Brien about BTK inhibitor Brukinsa’s latest lymphoma approval and offers messaging advice. Oprah’s primetime special on GLP-1 drugs tops our Trends segment, along with Olivia Rodrigo’s birth control giveaway and NewYork Presbyterian’s blood donation promo. Lecia Bushak has the week off. Music by Sixième Son

Check us out at: mmm-online.com

Follow us:

YouTube: @MMM-online

TikTok: @MMMnews

Instagram: @MMMnewsonline

Twitter/X: @MMMnews

LinkedIn: MM+M

To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

Music: “Deep Reflection” by DP and Triple Scoop Music.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen On

Apple PodcastsSpotify